Operating Company Healthcare

Veristat

Southborough, Massachusetts, United States

Science-first full-service clinical research organization (CRO) and consultancy providing strategic planning, regulatory expertise/support, biostatistics, medical writing, data management, and clinical trial execution for drug and biologic development.

Focus Areas
Contract Research Organization (CRO), Clinical development, Regulatory affairs
Website
veristat.com

Tracked deals

3

3 tracked deals across 2020-2026.

Recent pace

1

1 tracked deal announced in the last 12 months.

Deal mix

Buyout

3 buyout

Veristat Acquisition Volume by Year

Last 3 years

Acquisition volume by year Annual acquisition counts for the last 3 years for Veristat. 1 2020 1 2023 ~1 est. 1 2026
Actual Full-year estimate

Supporting Data

Recent Transactions

  • Veristat to Acquire Certara Regulatory and Medical Writing Business
    April 22, 2026
    Buyer
    Veristat, WindRose Health Investors, LLC
    Target
    Certara's Regulatory and Medical Writing business
    Seller
    Certara, Inc.
    Industry
    Healthcare Services
    Location
    Massachusetts, United States
    Type
    Buyout

    Veristat announced it has entered into a definitive agreement to acquire Certara’s Regulatory and Medical Writing business. The deal is expected to close in Q2 2026 and will add 200+ (approximately 220) medical writing and regulatory experts to expand Veristat’s regulatory writing, submission strategy, and advisory capabilities across the drug development lifecycle.

  • Veristat Acquires Instat Clinical Research
    October 19, 2023
    Buyer
    Veristat
    Target
    Instat Clinical Research
    Industry
    Healthcare Services
    Location
    New Jersey, United States
    Type
    Buyout

    Veristat, a full-service clinical research organization, has acquired Instat Clinical Research, a biometrics-focused CRO with teams in the United States and India. The deal expands Veristat's biometrics, data management, biostatistics, and statistical programming capabilities while adding offshore capacity to enable round-the-clock support for clinical studies.

  • Veristat Acquires The Clinical Trial Company Ltd (TCTC Group)
    January 6, 2020
    Buyer
    Veristat
    Target
    The Clinical Trial Company Ltd (TCTC Group)
    Industry
    Healthcare Services
    Location
    United Kingdom
    Type
    Buyout

    Veristat, a full-service CRO based in Southborough, Massachusetts, has acquired The Clinical Trial Company Ltd (TCTC Group), a Europe-headquartered contract research organization. The deal expands Veristat's European footprint and adds TCTC's expertise in gene and cell therapy, CNS and orphan disease clinical trials to Veristat's service offering.

Related Acquisition Pages

Healthcare Services Buyers & Acquisitions 3 tracked deals by Veristat. Acquisitions in Massachusetts 1 tracked deal by Veristat. Acquisitions in New Jersey 1 tracked deal by Veristat.

Related articles

Selling a company? Get in front of buyers like Veristat

Turn tracked acquisition activity into an outreach-ready buyer list.

Find buyers like these →